Santos da Silva Jorge

Chief Executive Officer, DirectorMoonLake Immunotherapeutics (MLTX) · full profile →Form 4 · filed Jul 13, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2.0M
Net Open-Market Flow
-$2.0M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 10, 2026Sell(S)68K$20.02$1.4M2.8M
Jul 9, 2026Sell(S)34K$20.01$679K2.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001213900-26-077564) within minutes of acceptance. Every field above traces to the original document. Verify it directly: